伊比利亚眼梅毒注册研究首报:半岛眼梅毒流行病学、临床谱与治疗结局
该多中心观察性队列研究纳入西班牙和葡萄牙23个中心新诊断的成人眼梅毒患者,首年39例参与,发病率0.57例/10万人年。多数为男性、男男性行为者及HIV合并感染,双眼受累和后节段受累常见。标准治疗后多数患者血清学和视力结局良好。
要点
- 眼梅毒多发于男性、男男性行为者及HIV合并感染者,双眼受累常见。
- 后节段受累(视网膜/脉络膜或视神经)比例高,临床谱广泛。
- 标准抗生素治疗后多数患者实现血清学滴度下降和视力改善。
核心结论
- 伊比利亚半岛眼梅毒临床谱广泛,后节段受累频繁,多数患者经标准治疗获得良好血清学和视力结局。
研究设计与样本
- 多中心观察性队列研究,覆盖西班牙和葡萄牙23个中心,纳入年龄≥18岁、经螺旋体和非螺旋体血清学试验确诊的新诊断眼梅毒患者。
- 首年41例符合纳入标准,39例同意参与注册,发病率为0.57例/10万人年。
主要发现
- 男性占94.9%,男男性行为者占66.7%,HIV合并感染占20.5%。
- 双眼受累占64.1%,前节炎症占64.1%,玻璃体炎占53.8%,视网膜或脉络膜受累占69.2%,视神经受累占59.0%。
- 全身梅毒分期:一期7.7%、二期25.6%、三期或四期15.4%。
- 症状出现后平均6.2±9.3周开始治疗,初诊后平均2.6±6.0周开始治疗。
- 静脉青霉素G使用率65.8%,最终访视(抗生素治疗后3至6个月)时61.3%实现反应素试验滴度四倍下降。
临床怎么用
- 对高风险人群(男男性行为者、HIV感染者)应警惕眼梅毒,注意双眼和后节段受累可能。
- 标准静脉青霉素G治疗可获较好血清学和视力结局,但需关注从症状出现到治疗的延迟。
局限性
- 样本量较小(首年39例参与),随访时间较短(3至6个月)。
- 观察性设计,数据收集基于常规临床实践,可能存在信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The Iberian Registry of Ocular Syphilis aims to describe the epidemiology, clinical manifestations and treatment outcomes of ocular syphilis in Spain and Portugal. This re-emerging condition, associated with rising global syphilis rates and HIV coinfection, presents with diverse ocular and systemic features. The study seeks to fill knowledge gaps regarding incidence, presentation and therapeutic response. METHODS: This multicentre, observational cohort study includes patients aged ≥18 years with newly diagnosed ocular syphilis confirmed by treponemal and nontreponemal serological tests. Conducted across 23 centres, data collection followed routine clinical practice and included demographics, ocular/systemic findings, treatment regimens and outcomes at 3-6 months post-treatment. RESULTS: In the first year, 41 patients met the inclusion criteria, of whom 39 consented to participate in the registry, with an incidence of 0.57 cases per 100 000 persons/year. Most were male (94.9%), especially men who have sex with men (66.7%) and HIV coinfection (20.5%). Bilateral ocular involvement was observed in 64.1% of patients, with anterior segment inflammation in 64.1%, vitritis in 53.8%, retinal or choroidal involvement in 69.2% and optic nerve involvement in 59.0%. Systemic syphilis stage included primary (7.7%), secondary (25.6%) and tertiary or quaternary (15.4%). Treatment was initiated after a mean of 6.2±9.3 weeks after the onset of symptoms, and 2.6±6.0 weeks after the initial presentation at the hospital. Intravenous penicillin G was used in 65.8%, and 61.3% achieved a four-fold titre reduction in the reaginic test at the final visit (3 to 6 months after antibiotic therapy). Final visual acuity improved to 0.17 LogMAR (p<0.001), with 56% of eyes gaining ≥0.1 LogMAR. CONCLUSIONS: Ocular syphilis in the Iberian Peninsula shows a wide clinical spectrum and frequent posterior segment involvement. Most patients achieved favourable serological and visual outcomes. These findings support the effectiveness of standard therapies and highlight the need for early diagnosis, especially in high-risk populations.
引用
- Vicente-Antolín M, González-López JJ, Pardiñas Baron N, et al. Iberian Registry of Ocular Syphilis (IBERSOS) report 1: epidemiology, clinical spectrum and treatment outcomes of ocular syphilis in the Iberian Peninsula. Br J Ophthalmol. 2026. PMID: 41791875. doi:10.1136/bjo-2025-328681
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。